ASIX

ASIX
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $374.473M ▼ | $27.425M ▲ | $-2.638M ▼ | -0.704% ▼ | $-0.1 ▼ | $20.921M ▼ |
| Q2-2025 | $410.022M ▲ | $25.416M ▲ | $31.371M ▲ | 7.651% ▲ | $1.17 ▲ | $53.366M ▲ |
| Q1-2025 | $377.791M ▲ | $23.409M ▲ | $23.344M ▲ | 6.179% ▲ | $0.87 ▲ | $49.648M ▲ |
| Q4-2024 | $329.062M ▼ | $21.733M ▼ | $352K ▼ | 0.107% ▼ | $0.013 ▼ | $8.328M ▼ |
| Q3-2024 | $398.187M | $24.265M | $22.266M | 5.592% | $0.83 | $51.602M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $23.696M ▲ | $1.688B ▲ | $870.115M ▲ | $818.232M ▼ |
| Q2-2025 | $18.446M ▲ | $1.646B ▲ | $822.67M ▼ | $823.732M ▲ |
| Q1-2025 | $8.344M ▼ | $1.626B ▲ | $831.606M ▲ | $794.368M ▲ |
| Q4-2024 | $19.564M ▲ | $1.595B ▲ | $820.27M ▲ | $774.65M ▲ |
| Q3-2024 | $17.298M | $1.51B | $743.827M | $766.408M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-2.638M ▼ | $26.588M ▲ | $-26.784M ▲ | $5.446M ▼ | $5.25M ▼ | $66K ▲ |
| Q2-2025 | $31.371M ▲ | $21.11M ▲ | $-31.424M ▲ | $20.416M ▲ | $10.102M ▲ | $-7.155M ▲ |
| Q1-2025 | $23.344M ▲ | $11.443M ▼ | $-36.794M ▲ | $14.131M ▲ | $-11.22M ▼ | $-22.619M ▼ |
| Q4-2024 | $352K ▼ | $64.165M ▲ | $-37.476M ▼ | $-24.423M ▼ | $2.266M ▼ | $29.816M ▲ |
| Q3-2024 | $22.266M | $57.25M | $-32.807M | $-19.25M | $5.193M | $26.76M |
Revenue by Products
| Product | Q3-2024 | Q4-2024 | Q1-2025 | Q2-2025 |
|---|---|---|---|---|
Caprolactam | $80.00M ▲ | $60.00M ▼ | $70.00M ▲ | $70.00M ▲ |
Chemical Intermediates | $120.00M ▲ | $80.00M ▼ | $90.00M ▲ | $110.00M ▲ |
Nylon Resins | $90.00M ▲ | $70.00M ▼ | $90.00M ▲ | $80.00M ▼ |
Ammonium Sulfate Fertilizers | $110.00M ▲ | $0 ▼ | $0 ▲ | $0 ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
AdvanSix today looks like a cyclical chemicals business coming off a boom period, with profits and margins normalizing toward more typical levels. Its financial foundation appears reasonably solid: moderate debt, growing equity, and steady positive operating cash flow, albeit with free cash squeezed by heavier investment spending. The company’s competitive strength lies in its low‑cost, vertically integrated production base, domestic orientation, and a portfolio that spans nylon, intermediates, and fertilizers. These factors help, but do not eliminate, the natural volatility of the sector. On the strategic side, AdvanSix is leaning into sustainability, specialty chemicals, and process innovation. If executed well, these initiatives could gradually shift the mix toward more differentiated, higher‑quality earnings, but they require ongoing capital and careful delivery in an already cyclical environment.
NEWS
November 7, 2025 · 6:30 AM UTC
AdvanSix Announces Third Quarter 2025 Financial Results
Read more
October 14, 2025 · 6:50 AM UTC
AdvanSix to Release Third Quarter Financial Results and Hold Investor Conference Call on November 7
Read more
September 2, 2025 · 4:15 PM UTC
AdvanSix Appoints Dana O'Brien and Daryl Roberts to Board of Directors
Read more
About AdvanSix Inc.
https://www.advansix.comAdvanSix Inc. manufactures and sells polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics and films.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $374.473M ▼ | $27.425M ▲ | $-2.638M ▼ | -0.704% ▼ | $-0.1 ▼ | $20.921M ▼ |
| Q2-2025 | $410.022M ▲ | $25.416M ▲ | $31.371M ▲ | 7.651% ▲ | $1.17 ▲ | $53.366M ▲ |
| Q1-2025 | $377.791M ▲ | $23.409M ▲ | $23.344M ▲ | 6.179% ▲ | $0.87 ▲ | $49.648M ▲ |
| Q4-2024 | $329.062M ▼ | $21.733M ▼ | $352K ▼ | 0.107% ▼ | $0.013 ▼ | $8.328M ▼ |
| Q3-2024 | $398.187M | $24.265M | $22.266M | 5.592% | $0.83 | $51.602M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $23.696M ▲ | $1.688B ▲ | $870.115M ▲ | $818.232M ▼ |
| Q2-2025 | $18.446M ▲ | $1.646B ▲ | $822.67M ▼ | $823.732M ▲ |
| Q1-2025 | $8.344M ▼ | $1.626B ▲ | $831.606M ▲ | $794.368M ▲ |
| Q4-2024 | $19.564M ▲ | $1.595B ▲ | $820.27M ▲ | $774.65M ▲ |
| Q3-2024 | $17.298M | $1.51B | $743.827M | $766.408M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-2.638M ▼ | $26.588M ▲ | $-26.784M ▲ | $5.446M ▼ | $5.25M ▼ | $66K ▲ |
| Q2-2025 | $31.371M ▲ | $21.11M ▲ | $-31.424M ▲ | $20.416M ▲ | $10.102M ▲ | $-7.155M ▲ |
| Q1-2025 | $23.344M ▲ | $11.443M ▼ | $-36.794M ▲ | $14.131M ▲ | $-11.22M ▼ | $-22.619M ▼ |
| Q4-2024 | $352K ▼ | $64.165M ▲ | $-37.476M ▼ | $-24.423M ▼ | $2.266M ▼ | $29.816M ▲ |
| Q3-2024 | $22.266M | $57.25M | $-32.807M | $-19.25M | $5.193M | $26.76M |
Revenue by Products
| Product | Q3-2024 | Q4-2024 | Q1-2025 | Q2-2025 |
|---|---|---|---|---|
Caprolactam | $80.00M ▲ | $60.00M ▼ | $70.00M ▲ | $70.00M ▲ |
Chemical Intermediates | $120.00M ▲ | $80.00M ▼ | $90.00M ▲ | $110.00M ▲ |
Nylon Resins | $90.00M ▲ | $70.00M ▼ | $90.00M ▲ | $80.00M ▼ |
Ammonium Sulfate Fertilizers | $110.00M ▲ | $0 ▼ | $0 ▲ | $0 ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
AdvanSix today looks like a cyclical chemicals business coming off a boom period, with profits and margins normalizing toward more typical levels. Its financial foundation appears reasonably solid: moderate debt, growing equity, and steady positive operating cash flow, albeit with free cash squeezed by heavier investment spending. The company’s competitive strength lies in its low‑cost, vertically integrated production base, domestic orientation, and a portfolio that spans nylon, intermediates, and fertilizers. These factors help, but do not eliminate, the natural volatility of the sector. On the strategic side, AdvanSix is leaning into sustainability, specialty chemicals, and process innovation. If executed well, these initiatives could gradually shift the mix toward more differentiated, higher‑quality earnings, but they require ongoing capital and careful delivery in an already cyclical environment.
NEWS
November 7, 2025 · 6:30 AM UTC
AdvanSix Announces Third Quarter 2025 Financial Results
Read more
October 14, 2025 · 6:50 AM UTC
AdvanSix to Release Third Quarter Financial Results and Hold Investor Conference Call on November 7
Read more
September 2, 2025 · 4:15 PM UTC
AdvanSix Appoints Dana O'Brien and Daryl Roberts to Board of Directors
Read more

CEO
Erin N. Kane
Compensation Summary
(Year 2024)

CEO
Erin N. Kane
Compensation Summary
(Year 2024)
Ratings Snapshot
Rating : A-
Most Recent Analyst Grades
Grade Summary
Price Target
Institutional Ownership

BLACKROCK, INC.
4.82M Shares
$74.176M

BLACKROCK INC.
4.787M Shares
$73.676M

VICTORY CAPITAL MANAGEMENT INC
2.178M Shares
$33.527M

VANGUARD GROUP INC
1.99M Shares
$30.626M

BLACKROCK FUND ADVISORS
1.745M Shares
$26.85M

DIMENSIONAL FUND ADVISORS LP
1.514M Shares
$23.307M

BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A.
1.316M Shares
$20.253M

STATE STREET CORP
1.047M Shares
$16.116M

AMERICAN CENTURY COMPANIES INC
967.571K Shares
$14.891M

ALLIANCEBERNSTEIN L.P.
948.491K Shares
$14.597M

WELLINGTON MANAGEMENT GROUP LLP
699.716K Shares
$10.769M

GEODE CAPITAL MANAGEMENT, LLC
635.2K Shares
$9.776M

LSV ASSET MANAGEMENT
622.706K Shares
$9.583M

CHARLES SCHWAB INVESTMENT MANAGEMENT INC
575.984K Shares
$8.864M

SOLAS CAPITAL MANAGEMENT, LLC
521.141K Shares
$8.02M

FIREFLY VALUE PARTNERS, LP
444.28K Shares
$6.837M

FMR LLC
408.887K Shares
$6.293M

MORGAN STANLEY
368.392K Shares
$5.67M

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
347.463K Shares
$5.347M

ROTHSCHILD & CO ASSET MANAGEMENT US INC.
313.339K Shares
$4.822M
Summary
Only Showing The Top 20


